4P Independent validation of the PAM50-based chemoendocrine score (CES) as pathologic complete response (pCR) and disease-free survival (DFS) predictor in hormone receptor (HR)+/HER2+ breast cancer (BC)
Titel:
4P Independent validation of the PAM50-based chemoendocrine score (CES) as pathologic complete response (pCR) and disease-free survival (DFS) predictor in hormone receptor (HR)+/HER2+ breast cancer (BC)
Auteur:
Pascual, T. Fernandez-Martinez, A. Tanioka, M. Dieci, M.V. Pernas Simon, S. Gavila Gregori, J. Guarneri, V. Cortés, J. Villagrasa, P. Vidal, M.J. Adamo, B. Muñoz, M. Griguolo, G. Llombart Cussac, A. Oliveira, M. Paré, L. Carey, L.A. Perou, C.M. Prat, A.